Eevia Health Plc has won a EUR 77,000 (SEK 868,000) sales order from a new North American brand owner. The order is the first commercial customer for Feno-Cerasus? 50 Organic, a new tart cherry extract product with the highest concentration of polyphenols when compared to competitive Tart Cherry extracts.

The end customer, a North American brand owner headquartered in the Mid-West US, is a fast-growing brand dedicated to organic, clean ingredients in its consumer products. They market dietary supplements and health foods across the US through different channels and outlets, including direct sales. The new customer is a significant market opportunity for Eevia Health.

Select Ingredients, a distributor of Eevia Health located in California, USA, made the sale. Select has a strong presence in the organic ingredients sector of the nutraceutical industry. The new order's sales value to Eevia is c. EUR 77,000 for Feno-Cerasus?

50 Organic. This extract made from organic tart cherries is standardized to a minimum of 50 % polyphenols and 7% anthocyanins, the highest concentration in the market. The order is the first commercial-size order for Eevia's cherry extract.

Tart Cherry anthocyanins and polyphenols have scientifically proven effects on human memory, concentration, and sleep quality, making them a compelling choice for health-conscious consumers. Eevia Health manufactures this extract with a superior purification technology compared to competitors, providing more than twice the bioactive concentration of what other manufacturers offer as well as a broader spectrum of polyphenols.